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Ninety percent of people with diabetes have Type 2 diabetes mellitus (T2DM). T2DM is 
a complex disease that affects every organ in the body, which makes effective 
management of the disease imperative. The American Association of Clinical 
Endocrinologist (AACE) and American College of Endocrinology (ACE)  strongly 
recommended early treatment initiation among the target population to delay disease 
progression and complications. The purpose of this evidence-based project was to 
examine the impact of using the T2DM management algorithm for effective management 
of adults with T2DM over a 3-month period. The shared experience decision-making 
model and chronic care model were used as a guide to implement the approach to 
practice. Implementation of the diabetes algorithm revealed a significant decrease in 
diabetes-related complications from 61.8% before implementation to 34.06% after the 
implementation.  A pre- and post-design was used to evaluate the impact of the 
interventional diabetes education among the 14 participants in the educational session. 
Diabetes education showed an increase in the participants’ knowledge of the disease with 
a prescore average of 56.91% compared to 90.72% post score. Early identification of 
individuals at risk of developing T2DM, an adaptation of the algorithm into practice, 
effective patient education, and efficient use of community-based resources, might 
decrease the incidence, prevalence, physical and financial burden, and psychosocial 
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Section1: Nature of the Project 
Introduction 
Type 2 diabetes mellitus (T2DM) is attributed to numerous risk factors such as 
genetic disposition, age, socioeconomic factor, and obesity. The ability to identify 
individuals with family history of T2DM, and obesity would enable the care provider to 
initiate appropriate interventions promptly and delay the progression of the disease. It is 
estimated that the onset of T2DM occurs an average of 4 to 7 years before clinical 
diagnosis. A high proportion of individuals exhibit evidence of end-organ damage by the 
time they are diagnosed (Forouhi & Wareham, 2014). The American Association of 
Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE)  
strongly recommend early treatment initiation in this population to delay disease 
progression and complications (Garber et al., 2017). A step by step management 
algorithm by  the AACE and ACE could be used by clinicians to initiate treatment in 
patients with substancial risk of T2DM promptly. The purpose of this evidence-based 
project is to evaluate the impact of early treatment of individual who have substantial risk 
of T2DM in delaying the progression of the disease. The goal is early prevention to 
prevent or delay the progression to advance diabetic status among the target population. 
Prevention is the key to reducing the incidence and prevalence of diseases such as 
diabetes by up to 50% (Backholer et al., 2013; Boyle et al., 2010; CDC, 2014).  Section 1 
of this project proposal will discuss the background, problem statement, purpose, 
practice-focus question and project objectives, theoretical frame works, nature of the 
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doctoral project, significance of the project, gaps in literature, implications for social 
change, and a summary. 
Background 
The project site is a non-profit primary care setting, in Destin, Florida that serves 
undocumented immigrants, homeless, and working Americans who are not able to afford 
medical insurance. The patient population at the clinic are predominantly individuals ages 
25 and above with low socioeconomic status and at least two chronic diseases such as 
hypertension, hyperlipidemia, diabetes, and coronary arterial disease (CAD). In 
comparison to patients with other chronic diseases, patients with T2DM are experiencing 
an increased rate of treatment failure due to a phenomenon called glycemic burden. 
Glycemic burden is a condition in which the patient’s cumulative glycated hemoglobin 
(HbA1c) exceeds the specified treatment goal regardless of therapy (Brown, Nichols, & 
Perry, 2004). 
The organization is currently using traditional guidelines for management of 
T2DM. The traditional guidelines do not require treatment initiation unless the patient is 
significantly symptomatic which is defined as having a non-healing wound, frequent 
infections, sudden weight gain or weight loss, HbA1c value greater than 10% in a routine 
blood test, diabetic neuropathy, and elevated urine protein. With the current guidelines, 
effective management of T2DM becomes complex because most of the patients have 
already developed diabetes-related complications before treatment is initiated.   
A retrospective review of patients’ medical records at the clinic over the last 5 
years demonstrated that more than 85% of the patients with T2DM were diagnosed late. 
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A late diagnosis results in treatment delay and related complications such as diabetic 
retinopathy, peripheral diabetic neuropathy, and cardiovascular problems.  An established 
protocol and guidelines for early diagnosis and prompt management of T2DM are 
imperative to the successful management and prevention of complications in adults with 
T2DM. Early treatment initiation is necessary to delay the progression and prevent 
disease-related complications, in patients with T2DM. The AACE and ACE strongly 
recommend early treatment initiation in this population to delay disease progression and 
complications (Pfeiffer, 2014; Brown et al., 2004; Garber et al., 2017).   
 Problem Statement 
Aside from numerous physical, psychological, and financial consequences faced 
by individuals affected by DM and their families, a long-standing uncontrolled 
hyperglycemia places the patient at higher risk for additional microvascular and 
macrovascular complications (Herman, 2011; McCulloch, 2014). The project site is a 
small non-profit primary care setting serving about 3,200 patients a year. The 
organization relies on community-based clinical providers who volunteer at the clinic to 
provide medical services to their patients. Currently, the organization has no specific 
treatment protocol for patients with T2DM such that the treatment plan and management 
is basically at the providers’ discretion. Treatment is not initiated until the patients 
become symptomatic as manifested by elevated HbA1c, a non-healing wound, frequent 
infections, and sudden weight gain or weight loss. Approximately 85% of the patients 
diagnosed with T2DM have one or more diabetes related complications.  
4 
 
Most of the patients have other comorbidities such as hypertension and 
hyperlipidemia that make the management of DM more complex. Based on the T2DM 
management algorithm, metformin should be initiated not only as a first line of therapy 
for the patient diagnosed with DM but also as a prophylaxis measure for the individual 
who has high risk of developing T2DM (Garber et al., 2017). Glucophage (metformin 
hydrochloride) is an oral antihyperglycemic agent that improves glucose tolerance in 
patients with T2DM by lowering both basal and postprandial plasma glucose (Bristol-
Meyers Squibb, 2017). Metformin is an appropriate drug for the target population 
because it does not affect insulin secretion while fasting (Bristol-Meyers Squibb, 2017) 
and is available to the patients from the project site at no cost from most of the 
neighborhood pharmaceutical companies. 
The impact of metformin in prevention of overt diabetes in individuals with high 
risk and prevention of complications in individuals diagnosed is well supported by 
numerous studies (see Crandall et al, 2008; DeFronzo & Abdul-Ghani, 2011; De 
Kruetzenberg et al., 2015; Diabetes Prevention Program Research Group (DPPRG), 
2012; Goldberg et al., 2017; Herman, 2011; Herman, 2015; Kelly et al., 2012; Malin, 
Gerber, Chipkin, & Braun, 2012; Marutur et al., 2013; Maji, Roy, & Das, 2005; Perreault 
et al., 2012). Standardization of care based on the T2DM algorithm would enable the 
providers to initiate treatment promptly in individuals with high risk of developing DM.    
Purpose Statement 
The primary purpose of this evidence-based project was to implement the diabetes 
management algorithm as the standard of care for patients with T2DM at the project site 
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and establish the benefits of metformin to individuals at risk of developing the disease 
based on the diabetes algorithm. The secondary purpose was to increase patients’ and 
providers’ awareness of the complexity of T2DM and emphasize the need for early 
treatment in individuals with high risk of developing T2DM to delay the progression of 
the disease and prevent complications in individuals diagnosed. Adequate understanding 
of the disease process for patients and providers would increase the patients’ compliance 
to treatment therapy and it would enable the providers to initiate treatment promptly in 
patients at risk of developing T2DM. An effective collaboration between patients and 
providers is crucial to optimal health care outcomes in the target population.  
Practice-Focused Question and Project Objectives  
The practice focused question was: Would early initiation of treatment with 
metformin based on the AACE and ACE diabetes management algorithms delay the 
progression of T2DM in individuals with high risk of developing the disease and prevent 
complications in individuals diagnosed with the disease?  The first project objective was 
to implement the diabetes algorithm as the standardized management guidelines of care 
for patients at high risk of developing T2DM as well as patients diagnosed with the 
disease to increase providers’ initiation of early treatment. To achieve the objective, a 
Power Point presentation on the significance of using the algorithm as the standard of 
care for diabetic management to help alleviate the issue of treatment failure was sent to 
all care providers via group email. It was also delivered to the providers at the providers’ 
quarterly meeting. The CDC prediabetes screening test from the National Diabetes 
Prevention Program (NDPP) (see Appendix A) and the patient risk assessment tool from 
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the ADA (see Appendix B) to help identify individuals at risk of developing T2DM and 
initiate immediate treatment dialogue with the patients were provided to care providers.  
The number of patients at risk of developing T2DM who were treated based on the 
traditional guidelines was collected over a 3-month period prior to the implementation of 
the algorithm and compared to the number of patients who were started on metformin and 
or referred to the community-based diabetes prevention program based on the algorithm 
for a 3-month period after implementation of the algorithm. Provider competency in the 
disease process and management of patients diagnosed with T2DM is imperative to 
actively engage patients in the context of patient-centered care and achieve optimal 
outcomes (Bernabeo & Holmboe, 2013).  
The second project objective was to increase the awareness of patients at risk of 
developing T2DM about the disease process and its management. Health literacy is the 
key to achieving effective chronic disease management and preventive health 
management and it strongly depends on patients and providers improved information and 
communication practices (Cavanaugh, 2012).  The ability of patients to be aware of risks 
and potential complications would enable them to make better-informed decisions and 
increase compliance with the treatment modality as initiated by their providers based on 
the algorithm. 
To attain the second objective, a Power Point presentation discussing T2DM, the 
disease process, its management, and complications was presented to patients at risk of 
developing T2DM. The patients who have a high risk of developing T2DM or were 
diagnosed with T2DM in the last 6 to 24 months were selected via the electronic medical 
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record (EMR) based on family history of diabetes, age (40 years and above) body max 
index (BMI), and existing medical comorbidities, such as hypertension and 
hyperlipidemia. They were sent a follow-up letter (see Appendix C) to notify them of 
risks and the various treatments available to them at no cost to ask for their participation 
in diabetic education that would take place at the project site to improve their knowledge 
of the disease and enhance their self-care management. A pre-and post-intervention test 
was conducted to evaluate the patients’ level of understanding of T2DM and its 
management. A pamphlet version of the power point presentation was also provided to 
each participant and it was available in each examination room in both English and 
Spanish languages.  
  The ability of providers and patients to adequately understand the disease process 
would increase the patients’ adherence to the treatment modality and promote positive 
patients’ outcomes (Cavanaugh, 2012; Adams, 2010). Mutual collaboration between 
patients and providers is essential for total glycemic control, effective management of the 
disease, complications prevention, medication compliance, and successful patient health 
outcomes (McCulloch, 2014; Shrivastava, Shrivastava, & Ramasamy, 2013). In primary 
care, patients’ adequate knowledge of the disease process and active participation in their 
care is crucial to efficient transition of care from the clinical setting to home environment 
(Shrivastava & Ramasamy, 2013; Sayah et al., 2012). 
Gap in Practice 
Prior to the evidence-based proposal, there was no specific standard of care or 
treatment guidelines in place for the management of T2DM at the project site. Disease 
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management was basically at the providers’ discretion. Patients were screened for 
diabetes when presenting with conditions such as a non-healing wound, frequent 
infection, sudden weight gain or weight loss, or an HbA1c value greater than 10% in a 
routine blood test.  Treatment is then initiated after the result of screening confirmed the 
presence of the disease. The length of time from the point at which the patient 
experienced the first symptom to the diagnosis and initiation of treatment can be as long 
as 9 to 12 months.  
An individual could be developing T2DM for as long as 7 years before he or she 
presents with the first symptom (Forouhi & Wareham, 2014). However, by the time the 
patient is diagnosed, one or more organs may already be affected. With progression of 
T2DM, the treatment plan becomes more complex and the prognosis becomes poorer. 
Therefore, adaptation of the diabetes management algorithm for the management of 
patients with T2DM from the AACE and ACE would enable providers to promptly 
initiate treatment based on the algorithm. With early intervention, the progression of 
T2DM may be delayed using cost-effective monotherapy such as metformin to achieve 
overall positive health care outcomes (Garber et al., 2017). Establishment of a 
standardized evidence-based practice (EBP) would bridge the gap in inequality of patient 
care and disparities in health care. By using the diabetes mangement algorithm to manage 
T2DM at the project site, the patients are able to receive the same quality evidence-based 
care just as their counterparts with medical insurance. 
Nature of the Doctoral Project 
9 
 
The nature of the project was to determine the impact of providers’ adequate use 
of the diabetes management algorithm to initiate early treatment in patients with high risk 
of developing T2DM at the project site. To evaluate the providers’ utilization of the 
algorithm, a comparison of the number of patients at risk of developing type 2 DM who 
were started on early treatment collected over a 3-month period prior to the 
implementation of the algorithm, to the number of patients who were started on 
metformin and referred to the community-based diabetes prevention program based on 
the algorithm after a three-month period was completed. The comparison shows a clear 
measure of effects of the intervention. 
The project also evaluated the knowledge of patients at risk of developing T2DM 
its disease process, management, and complications.  A quasi-experimental design of 
one-group pretest-posttest approach was used to evaluate the increase in patients’ 
knowledge regarding their management of T2DM. The presentation took place in the 
conference room at the project site. The presentation discussed T2DM, it etiology, 
contributing factors to the progression and complications of the disease, the importance 
of adequate knowledge and self-care management. The information was presented at a 
fifth grade level with limited medical verbiage for patients’ comprehension (Badarudeen 
& Sabharwal, 2010).  The approach enabled the establishment of baseline knowledge 
regarding patients’ understanding of the complexity and multi-faceted nature of T2DM. 
At the end of the Power Point presentation, the patients were given the posttest. Result of 
the pre and post-test were compared to evaluate the change in knowledge of the patients 
regarding T2DM. Statistical Package for the Social Science (SPSS) version 24.0 was 
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used to compute a paired sample t-test to accurately analyze patients’ knowledge of 
T2DM, its disease process, management, and complications.  
Significance of the Project 
About 29.1 million American are currently diagnosed with diabetes, and the 
number could be doubled if total control of T2DM cannot be achieved by the year 2020 
(Healthy People 2020, 2011). Prevention is the key to reduce the incidence and 
prevalence of diseases such as diabetes by up to 50% (Backholer et al., 2013; Boyle et al., 
2010; CDC, 2014). Healthy People 2020 (2011) said “Through prevention programs, 
reduce the disease and economic burden of diabetes, and improve the quality of life for 
all persons who have or are at risk for diabetes”. 
Use of the diabetes algorithm affords providers the clear evidence from well-
conducted studies to deliver an evidence-based quality of care. The guidelines as a 
standard of care serve for providers to develop a customized patient plan of care based on 
the algorithm and initiate treatment promptly as deemed. Prompt intervention decreases 
the burden of poor glycemic control as well as long-term complications of metabolic 
syndrome (Backholer et al., 2013). Standardization of care based on the algorithm would 
provide consistency in practice and promote effective continuity of care.   
Effective patient-provider collaboration of care would not only improve patients’ 
compliance with the treatment regimen, but also promotes patients’ sense of involvement 
in care that leads to the achievement of healthcare goals and positive clinical outcome 
(Cavanaugh et al., 2009). By increasing patients’ awareness of the complexity of T2DM, 
there should be an increase in positive self-care behaviors, such as dietary modifications 
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and routine exercise. Above all, the use of the algorithm will enhance the cost-
effectiveness of providing care, increase access to care and decrease health disparities 
among the target population.  
Implications for Social Change 
Standardization of diabetes care based on the diabetes management algorithm for 
providers, identification of the individuals at risk of developing T2DM, and prompt 
initiation of treatment are imperative to decrease treatment failure in the target 
population.  The providers’ knowledge of the complexity of the disease process would 
enable them to screen individuals at risk of developing T2DM, initiate treatment 
modalities earlier, and use other community-based resources such as the diabetes 
prevention program and medication assistance program to attain the best patient care 
outcomes.  The success of early treatment and elimination of treatment failure will 
improve both short-and long-term outcomes in patients at risk for and currently 
diagnosed with T2DM.  
 Increasing patients’ knowledge and awareness of T2DM is essential to the 
achievement of optimal health care outcome. Patients’ adequate understanding of the 
disease process will heighten their commitment to treatment modalities and self-care 
management.  Active patients’ involvement and participation in care would not only 
optimize their compliance with care, but also promote their sense of involvement and 
ownership of care.  Above all, to hinder the progression of T2DM and prevent 
complications related to the disease, a robust evidence-based practice such as the diabetes 
algorithm must be adopted into practice. Adaptation of the algorithm into practice, 
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effective patient-provider collaboration of care and efficient use of community-based 
resources are necessary to decrease the incidence, prevalence, physical burden, 
psychological impact, financial constraints, and other complications o T2DM.  
Summary 
The rate of treatment failure of patients diagnosed with T2DM at the project site 
is incredibly high because treatment is based on providers’ discretion. The goal was to 
change the management of patients diagnosed with T2DM from a treatment-based to a 
prevention-based focus. Therefore, standardized and evidence-based guidelines need to 
be adapted by providers to ensure a consistent approach to management of T2DM and 
earlier initiation of treatment strategies for patients at risk. Adaptation of the diabetes 
management algorithm will enable providers to effectively screen patients at risk of 
developing T2DM based on their risk factors, initiate treatment early, and make 
appropriate referrals to community-based diabetes prevention programs. The nature of 
the project was to determine the impact of the providers’ use of the algorithm to initiate 
early treatment in patients at risk of developing T2DM and to evaluate the knowledge of 
the patients at risk of developing T2DM, its disease process, management, and 
complications. The significance of the project to clinical practice is that it provides the 
providers a concise and step-by-step evidence-based guideline to develop a customized 
patients’ plan of care. The implication of the project to social change is that it increases 
the knowledge of both the providers and patients about the complexity of the disease and 
the need for early treatment. Mutual understanding of the disease process promotes 
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treatment compliance among patients and attainment of optimal healthcare outcomes a 























Section 2: Background and Context 
Introduction 
T2DM is a very complex disease and its management is cumbersome in addition. 
The complexity of the disease process could easily become overwhelming to both 
patients and providers. Adequate awareness of the disease process for patients, use of a 
standardized treatment guidelines such as the diabetes management algorithm by the 
AACE and ACE, early identification of patients at risk of developing T2DM, and 
effective use of community-based resources such as the Florida diabetes preventive 
program are crucial to effective and efficient management of chronic disease such as 
T2DM, thereby eliminating treatment failure. In this section, the shared experience 
decision-making model and the chronic care model (CCM) are the two theoretical 
frameworks that will be used to systematically integrate the new approach to practice. 
The background and content of the EBP, its relevance to nursing practice, the role of the 
DNP student, the role of the project team, and the definitions of terms used will be 
discussed.  
Concepts, Models and Theories 
To systematically integrate the new approach to practice, and improve patients’ 
and providers’ awareness of T2DM and promote patient self-care management and 
empowerment, the shared experience decision-making model and CCM were used to 
orchestrate the process. The shared decision-making process promotes a collaborative 
and joint effort between the health care provider and the patient to arrive at the best 
health care choice that is suitable for the individual patient based on the best available 
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research evidence, and the patient’s own values. The shared decision-making model 
consists of three key concepts which are evidence in clinical practice, incorporation of the 
evidence into clinical practice, and emphasis on the individual patient’s value in the 
decision-making process (Friesen-Storms et al., 2015).  
With about 85% of patients diagnosed with T2DM having at least one diabetes 
related complication, the need for EBP and standardized clinical practice for the 
management of patients with T2DM is necessary at the project site. The T2DM 
management algorithm is essential to meet the need for a robust EBP for effective 
management of the target population. Adaptation of the algorithm into clinical practice 
would enable providers to identify individuals at risk of developing T2DM and initiate 
treatment promptly.  Adequate patient education about T2DM becomes the driving force 
for patients to be more involved in their plan of care. Patients’ health literacy is vital for 
effective contributions to their health care decision-making process. The shared decision-
making model helped provide a mutual effort between providers and patients to develop a 
consensus on screening for T2DM, its diagnosis, and effective interventions based on the 
algorithm for best health outcomes. A robust evidence-based practice decision-making 
environment must intergrate evidence into the intervention, clinical expertise, and must 




Figure 1. EBP Decision-Making Environment Model. From “Shared Decision Making in 
Chronic Care in the context of  Evidence-Based Practice in Nursing,” by J. H.H.M. 
Friesen-Storms, G.J.J.W. Bours, T. V. D. Weijden, and A.J.H.M. Beurskens, 2015,  
International Journal of Nursing Studies, 52(1), 393–402. 
 
The CCM is another theoretical framework suitable to promote patients’ personal 
empowerment related to self-care and collaboration of care between provider and patient; 
and enhance continuity of care in patients with T2DM. The focus of CCM is to enhance 
use of available resources, promote patients’ comprehension of disease processes and 
promote an upbeat health care team. Its features are establishment of a health system and 
organization of health care to provide leadership for securing resources and removing 
barriers to care, creation of self-management support to facilitate skills-based learning 
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and patient empowerment for patients, promotion of decision support that guides 
implementing evidence-based care, development of  delivery system designed to 
coordinate care processes, provision of  clinical information systems to track progress 
through reporting outcomes to patients and providers, and enhancement of community 
resources and policies that sustains care by using community-based resources and public 
health policy (Baptista et al., 2016).   
Establishment of a health system and organization of health care to provide 
leadership for securing resources and removing barriers to care is the first feature of the 
CCM.  Lack of standardization of care is one of the contributing factors to treatment 
failure in patients with T2DM at the project site. Establishment of standardized treatment 
guidelines such as the algorithm for management of T2DM is a change that must be 
adopted into practice by the care providers in the organization to alleviate treatment 
failure. The organization’s ability to embrace the guidelines would promote safe and high 
quality care and management of errors remove barriers to care, and advance quality 
control (Baptista et al., 2016).  
The second feature of the CCM is the creation of self-management support to 
facilitate skills-based learning and patient empowerment. Lack of patient awareness of 
T2DM, its disease process, management, and complication are major contributing factors 
to poor patient health care outcomes in the target population.  Creation of self-
management support  that facilitate skills-based learning and patient empowerment  is 
imperative. Adequate patient education that empowers the patients and emphasizes their 
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role in effective self-management is necessary for successful achievement of desired 
patient health care goals. 
Promotion of decision support that guides implementing evidence-based care is 
the third feature of the CCM. Inconsistency in management of patients diagnosed with 
T2DM and late initiation of treatment in patients with high risk of developing T2DM at 
the project site are due to lack of clear evidence-based clinical guidelines such as the 
algorithm. Availability of evidence-based clinical guidelines to support clinical decision 
promotes consistency in delivery of care. Use of the guidelines will enable the providers 
to screen individuals at risk and initiate treatment promptly.  
Development of  a delivery system designed to coordinate the care processes is 
the fourth feature of the CCM. Effective management of T2DM is very complex and a 
multidisciplinary team that focuses on individual structured care must be developed. 
Development of a delivery system designed to coordinate care process is necessary to 
achieve health care goal for patients with T2DM.  
The fifth feature of the CCM is the provision of  clinical information systems to 
track progress through reporting outcomes to patients and providers. Individual patients’ 
customized plans of care and desired clinical health care goals must be developed. 
Provision of  clinical information systems that track the progression of patient outcomes 
is imperative for efficient and effective management of the diseases.  
The sixth and the last feature of the CCM is an enhancement of community 
resources and policies that sustains care by using community-based resources and public 
health policy. Efficient transition of care from the clinical setting to home environment is 
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the ultimate goal in management of patients with chronic disease such as T2DM in 
primary care system (Shrivastava  & Ramasamy, 2013). Use of community-based 
resources such as the state diabetes preventive program, medication assistance program 
by the neighborhood pharmaceutical companies, and provision of diagnostic tests by the 
community philanthropies are imperative not only to meet the patients’ need but to attain 
the best patient care outcomes and sustenance of care. Enhancement of community 
resources and policies that sustain care by using community-based resources and public 
health policy is essential to efficient and effective management of chronic disease such as 
T2DM. Establishment of partnerships between healthcare systems, organization, patients, 
families, and the communities are adamant to the successful patient health care outcome 






Figure 2. Chronic care model from “The Chronic Care Model for Type 2 Diabetes: A 
Systematic Review” by D. R. Baptista, A. Wiens, R. Pontarolo, L.Regis, W. C. Torelli 
Reis, and C. J. Correr, 2016. Diabetology and Metabolic Syndrome, (8)7, 1-7. 
Relevance to Nursing Practice 
T2DM is a very complex, and multifaceted disease. The disease process and its 
progression are very complicated such that an individual could have the disease for as 
long as seven years before the first symptom emerged. By the time the patient is 
diagnosed, he or she typically already has developed complications related to the disease 
(Forouhi & Wareham, 2014). Due to the depth-of the disease progression before 
diagnosis, the disease management become cumbersome and treatment failure ensue. 
Clinicians, providers, stakeholders, patients, and families are greatly affected by the 
burden of the treatment failure. It is projected that the number of Americans diagnosed 
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with diabetes and the government expenditure related to the disease will double by the 
year 2020, if no drastic measure is taking to curtail the disease progression (Healthy 
People 2020, 2011).  
While it is impossible to eliminate the hereditary risk factor of T2DM, risk factors 
such as diet and weight can be managed effectively and thereby delay the progression of 
the disease and prevent complications related to the disease.  Primary prevention is the 
key to efficient and effective management of T2DM to prevent individuals at risk of 
developing T2DM to overt diabetes.  Early treatment would reduce the incidence, 
prevalence, economic burden, and improve the quality of life individuals diagnosed or are 
at risk of developing T2DM (Healthy People 2020, 2011).  
The cost of diabetes and diabetes related complication are another fact that makes 
early treatment imperative among the target population. Most of the patients cannot 
afford their medications, and they rely on the medication assistance program. The 
providers, care managers, and social workers work relentlessly to explore various 
pharmaceutical companies for medication assistance and other needs from the community 
resources for these patients. Early treatment initiation in individuals with substantial risk 
of diabetes with metformin (Garber et al., 2017) noted in the algorithm, is a win-win for 
this population. There are few community-based pharmaceutical companies such as 
Publix and Winnie Dixie that provide metformin at no cost to patients at the project site. 
However, when the disease is advance to class A2 as described by Klemetti et al. (2016) 
in which insulin therapy is required to manage the disease, the treatment modality 
becomes cumbersome in the target population. Because attainment of insulin from the 
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medication assistance program is not guaranteed, which could place the patients at a 
disadvantage and the health outcomes become threatened.   
T2DM is a composite disease, and individualized patient treatment plan and 
ongoing clinical support are essential to attain positive patient health care outcome 
(Robertson, 2012). The success of early treatment initiation strongly depends on the 
cooperation among clinicians, the organization, and providers. It is imperative that 
providers be aware of patients at risk and initiate the dialogue for early intervention 
promptly. Adequate and efficient patient education would enable patients to make an 
informed decision towards their health. The development of a collaborative care approach 
between patients and their providers along with, customized patient-centered plan of care 
are the recipes to a successful clinical outcome and attainment of patients’ health care 
outcome in the target population. 
Local Background and Context 
The project site is a clinic operated by a non-profit organization, and providers are 
volunteers. The Hope committee does not interfere with the clinical aspect of the clinic 
activities. Their focus is to provide the providers with resources to perform the job. The 
committee consists of 10 retired nonmedical personnel and two retired public health 
personnel. The medical director is a volunteered retired cardiologist.  Unlike the 
Medicare and Medicaid funded organizations that are required to develop patients’ 
treatment plan based on a specific guideline, the providers at the project site are not under 
a specific guideline and no quality control based on evidence-based practice is in 
existence. The treatment plan for patients with T2DM is not begun unless patients 
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become symptomatic or the HbA1c is 10% or above. Currently, there are no specific 
guidelines or protocols in place for the management of T2DM. The treatment plan and 
management is basically at the providers’ discretion. A standard of care for every disease 
process must be established, like the diabetes management algorithm and it must be part 
of quality core measures for the clinic’s quality of care.  
Despite the ongoing global propaganda regarding the impact of T2DM, its 
management, and the effect of early treatment in delaying the progression of the disease; 
the Florida state legislature has no legislation in place to help speed up the adaptation of 
the evidence-based practice into practice by every provider.  According to Krieger 
(2008), the practice of government and political priorities are the proximal determinants 
that govern the distal determinants which are the society’s economy, social patterns, 
physical, behavioral, psychosocial, and biological exposures that trigger pathogenic, 
processes thereby causing disease. A political ideology that undermines the significance 
of health and healthy living is a catalyst for the public’s adverse health care outcome. 
The proximal-distal phenomenon creates a class and racial inequality that 
differentially affect the living standards, working conditions, and environmental 
exposures of the dominant and subordinated classes and racial/ethnic groups (Krieger, 
2008).  The phenomenon leads to social class inequality and racial/ethnic health 
disparities. The only way the proximal-distal phenomenon leading to health disparities 
can be eliminated is to have legislation that mandates a standardized, evidence-based 
quality of care to all patients regardless of socioeconomic status and racial/ethnic groups.  
Definition of Terms 
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 The following are the definitions of relevant terms used in this paper: 
Adenosine Monophosphate-activated Protein Kinase (AMPK):  An enzyme that 
speed up metabolism and burn fat when activated (De Kreutzenberg et al., 2015). 
Athena: A computer system use by the clinic site for clinical decision support 
(CDS). 
Body Mass Index (BMI): A person’s weight in kilograms divided by the square of 
height in meters.  It is moderately correlated with more direct measures of body fat 
(CDC, 2016).  
Diabetes management algorithm: The standard and recommendations guidelines 
established by endocrine governing bodies based on the most current clinical evidence for 
efficient and effective of diabetes (Garber et al., 2017).  
Diabetic nephropathy: Damage to small blood vessels in the kidneys (WHO, 
2017) 
Peripheral diabetic neuropathy: A dysfunction of cardiac autonomic activity 
(Bansal, 2015).   
Diabetic retinopathy: Small blood vessel damage to the back layer of the eye, the 
retina, leading to progressive loss of vision, even blindness (WHO, 2017).  
Euglycemic: Normal blood glucose (or, blood sugar). It is also referred to 
as normoglycemia (Bansal, 2015).  
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Glycemic burden: A condition in which the patient’s cumulative glycated 
hemoglobin (HbA1c) exceeds the specified treatment goal regardless of therapy (Brown, 
Nichols, & Perry, 2004). 
Glycated hemoglobin (HbA1c): A biochemical marker that is used to monitor the 
long-term glycemic control and assess the risk of developing complications (Yedla, 
Kuchay, & Mithal, 2015). 
Hyperglycemia: When the blood glucose level is too high because the body isn't 
properly using or doesn't make the hormone insulin (Hess-Fischl, 2015). 
Hypoglycemia: A condition characterized by abnormally low 
blood glucose (blood sugar) levels, usually less than 70 mg/dl (McCulloch, & Mulder, 
2016). 
Overt diabetes: Progression of pre-diabetes condition to full clinical diabetes 
stage (Maruthur et al., 2013).  
Pre-diabetes: An intermediate state of hyperglycemia with glycemic parameters 
above normal but below the diabetes threshold (Bansal, 2015). 
Treatment failure: Inability to achieve clinical treatment goal (Brown et al., 
2004). 
Type I diabetes: A congenital defect that results in decrease insulin production by 
the pancreatic beta cells (Punjab, 2016). 
Type II diabetes: Resistance to the action of insulin of different target tissues such 
as muscle, liver, and adipose, which ultimately leads to an impaired glucose uptake for 
these organs (Punjab, 2016). 
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Therapeutic Lifestyle Changes (TLC): Lifestyle component that focuses on 
healthy eating pattern, weight management, and increased physical activity (CDC, 2016). 
Role of the DNP Student 
Clinical prevention and population health for improving the nation’s health is one 
of the academic requirements for the Doctor of Nursing Practice (DNP) curriculums 
essential for all DNP graduates (AACN, 2006). It is vital for a DNP as an agent of change 
and empowerment to develop and promote, health promotion and disease prevention 
activities for individuals, aggregates, and population (AACN, 2006). According to Center 
for Disease Control and Prevention (CDC) (2015), about half of preventable deaths in the 
United States (U.S) are related to unhealthy lifestyle, lack of adequate screening for 
diseases, and obesity. The DNP graduate’s ability to engage in leadership that integrate 
and institutionalize evidence-based clinical prevention and disease management is 
indispensable (AACN, 2006). As a DNP student, I feel compelled and obligated that the 
population served at the project site should receive the same quality care and most current 
evidence-based standard of care for everybody else in the community regardless of their 
socioeconomic status and or racial/ethnic background.  
After the approval of the Walden’s Internal Review Board (IRB) to implement the 
project and the execution of the project is also approved by the sponsor at the project site, 
I met with the team to discuss about the project. Then I developed the schedule and the 
activities of the project based on the organization’s hours of operation. I was the project 
manager for the project team. As described by Thomas, Jacques, Adams, & Kihneman-
Wooten, (2008) my responsibility as the project manager, includes successful initiation, 
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planning, design, execution, monitoring, and evaluation of the project. My goal was to 
complete the project in twelve weeks and on time as scheduled without delay or 
hindrances. Although the process of a project implementation could be very cumbersome 
and challenging, but with these team members on my side, the project it was a success. 
Role of the Project Team 
Project planning and team development are integral parts and process of a project. 
They must be developed and initiated simultaneously with the project (Thomas et al., 
2008). The role of each project team members and effective management of such role is 
critical to the successful outcome of the project. The success of any project strongly 
depends on well-considered, well-developed, and outstanding, committed team members 
(Thomas et al., 2008). I was the project manager, my preceptor was the sponsor as the 
director of the organization, and the other team members are the Spanish interpreter, who 
is a volunteer at the clinic and the project site care coordinator, who is an employee of the 
organization. The role of the Spanish interpreter is very crucial to the project as 50% of 
the population served at the project site is Spanish speaking only. The project site care 
coordinator coordinates the EMR review and served as the liaison between the project 
team, project manager, the patients, providers, and other stakeholders. A well strategic 
plan and committed team members are the precursors to a successful project outcome. 
Summary 
 T2DM is identified as one of the complex chronic diseases to manage in primary 
care. Its multi faceted disease characteristics required a multidisciplinary team 
management to be managed efficiently and effectively. Use of a standardized treatment 
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guideline such as the diabetes management algorithm serves as a blue print for a provider 
in the identification of patients at risk of developing T2DM.  The ability of the providers 
to identify individuals at risk would result in prompt treatment initiation. Adequate 
patient knowledge of the disease process and judicial use of community-based resources 
such as the diabetes preventive program are essential to the effective and efficient 
management of T2DM, thereby alleviating treatment failure in the target population. The 
shared experience decision-making model demonstrates that a robust EBP decision 
environment must integrate evidence of the clinical intervention, clinical expertise, and 
incorporation of patient’s value at all level to achieve the utmost clinical outcome. The 
CCM framework promotes patients’ empowerment related to self-care management, a 
collaboration of care between providers, patients, organization, and continuity of care in 
patients with T2DM. The background and content of the EBP were identified as lack of 
standard of care for the management of T2DM by the providers and the need to adapt the 
algorithm to decrease treatment failure. The relevance of the project to the nursing 
practice is a reduction the incidence; prevalence, economic burden, and improvement of 
the quality of life of individuals diagnosed or that are at risk of developing T2DM. My 
role as an agent of change and empowerment was to develop and promote health 
promotion and disease prevention activities for individuals, aggregates, and target 
population. The role of every project team members and effective management of such 








Section 3: Collection and Analysis of Evidence 
Introduction 
The purpose of this evidence-based project are to implement the diabetes 
algorithm as the standard of care for the management of T2DM at the project site, 
increase patients’ and providers’ awareness of the complexity of the disease, the need for 
early treatment of individuals at high risk of developing T2DM to delay the progression 
of the disease in individuals at risk of developing the disease, and prevention of 
complications related to the disease in diagnosed individuals. The clinic has experienced 
significant level of treatment failure with about 85% of patients diagnosed with T2DM 
having one or more additional microvascular and macrovascular complications due to a 
lack of standardized treatment protocol. A robust and standardized evidence-based 
practice is needed to alleviate the gap in treatment failure in the target population. 
Numerous studies support early treatment of individuals with a high risk of developing 
T2DM with metformin based on the algorithm (see Herman, 2015; Kreutzzenberg et al., 
2015; Malin et al., 2012; Maruthur et al., 2013). An extensive review of literature is 
discussed in this section, in addition to sources of evidence, the practice-focused 





Currently, there is no specific guideline or protocol for the management of T2DM 
at the project site. Management of the target population is basically at the individual 
provider’s discretion. The lack of standardization of treatment results in treatment failure 
and glycemic burden. An established standard of care is imperative to address these 
issues. The purpose of this project was to implement an evidence-based standard of care 
such as the algorithm for patients T2DM, to prevent patients at risk of developing T2DM 
from developing overt diabetes and diabetes-related complications in individuals 
diagnosed with the disease. Hence, the practice-focused question was: Would early 
initiation of treatment with metformin based on the AACE and the ACE diabetes 
management algorithm delay the progression of T2DM in individuals with a high risk of 
developing the disease and prevent complications in individuals diagnosed with the 
disease?  
Sources of Evidence 
The review of literature for evidence was conducted using the databases PubMed, 
MEDLINE, CINHAL, National Institutes of Health (NIH), CDC, and the Cochrane 
Library via Walden University to identify studies that focused on the effects of early 
intervention in patients with T2DM and used metformin as a prophylaxis in patients with 
potential risks of developing diabetes and pre-diabetes based on the diabetes management 
algorithm. Studies that examine the cost-effectiveness of metformin were also identified. 
The key terms and combination of words used were: diabetes, type II diabetes, 
complications, risk factors, and cost of care. Searched articles were published between 
2006 and 2017 to obtain the most current evidence-based and peer-reviewed articles. The 
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studies were selected based on the aim of the study, outcome of the study, population 
sample size, research design, and levels of evidence, strengths and weaknesses of each 
study. The initial results of the search generated 2,800 articles related to prevention and 
early treatment of diabetes. The number of the article was narrowed down to 500 after 
adding metformin as the intervention for prevention and early treatment of T2DM. The 
articles were further narrowed down to 10 by selecting articles in which metformin was 
used as either the primary preventive intervention for T2DM or as an adjunct with 
another intervention such as lifestyle changes based on the diabetes algorithm.   
Literature Review 
 Maruthur et al. (2013) examined the relationship between early measures 
of weight and glucose control in patients with a high risk of developing T2DM who used 
metformin and lifestyle modification in a diabetes prevention program and found there 
was a 58% decreased risk of overt diabetes in the metformin group as compared to the 
lifestyle and placebo groups. It was also shown that a significant (p=0.038) interaction 
between weight loss and glucose does exist (Maruthur et al., 2013). The study 
demonstrates the effectiveness of metformin alone in overt diabetes prevention and its 
ability to potentiate the effectiveness of lifestyle modification when added to a treatment 
plan.  The implication of the study to practice is that metformin can be used 
independently as a monotherapy or in conjunction with another intervention to prevent 
overt diabetes in individuals at risk.  
 The DPPRG (2012) revealed a reduced body weight by 7%, weight 
circumference, and waist circumference in the metformin group compared to the placebo 
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(DPPRG, 2012). Gastrointestinal symptoms were seen among the metformin group at the 
beginning of the intervention but subsided over time. The metformin group maintained 
weight loss when evaluated during follow-up (DPPRG, 2012). The incidence of diabetes 
was reduced by 34 % in the metformin and 18 % in the lifestyle group as compared to the 
placebo (DPPRG, 2012). The study supports the project by showing that early treatment 
initiation with metformin as recommended by the diabetes management algorithm for 
individuals at risk helps gain efficient glucose control and weight management.  
Herman (2015) compared the cost efficiency of lifestyle changes, metformin, and 
placebo in a diabetes progression prevention program. There was a reduction in 
prevalence of diabetes rate by 34% in the lifestyle group and 18% in the metformin group 
as compared to the placebo group (Herman, 2015).  It was also discovered that the 
lifestyle modification and metformin interventions were more expensive than the placebo 
intervention, but their costs were offset by reductions in the costs of nonintervention-
related medical care. Metformin alone as an intervention has the potential to delay the 
progression of T2DM to u pto 10 years and the progression can be further extended up to 
18 years when combined with diet and exercise (Herman, 2015). The implication of the 
study to clinical practice is imperative because patients can be managed with metformin 
in spite of their ability to comply with lifestyle modifications and delay the progression of 
the disease.   
De Kreutzzenberg et al (2015) assessed the impact of metformin in modifying the 
alleged effectors of longevity in peripheral mononuclear cells of patients with 
prediabetes. Pre-intervention and post- treatment anthropometric and metabolic 
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parameters were collected for comparison (De Kreutzenberg et al., 2015). Metformin 
effectively prevented the progression of prediabetes to overt diabetes among the subjects 
and also significantly blunted inflammation, improved cell survival, and exerted 
anticancer effects by suppressing the mammalian target of rapamycin (mTOR)/S6K1 axis 
(De Kreutzenberg et al., 2015). Metformin targets AMP-activated dependent kinase 
(AMPK) (see definition of terms) and thereby increases cellular resistance to stress, 
inflammation, and aging (De Kreutzenberg et al., 2015). De Kreutzenberg et al. (2015) 
said that metformin delays progression of T2DM; it also suppresses the aging process at 
the same time. Increase in age is one risk factor for developing T2DM. The older an 
individual, the higher the risk of developing T2DM (De Kreutzenberg et al., 2015). 
Perreault et al. (2012) conducted a randomized clinical trial to compare the impact 
of lifestyle changes with metformin, lifestyle only, and placebo in the progression of pre-
diabetes to overt diabetes. The outcome revealed that the lifestyle and metformin group 
had a higher number of participants that returned to normal glucose regulation (NGR) as 
compared to lifestyle alone and placebo groups (Perreault et al., 2012). The conclusion of 
the study also supports the effectiveness of metformin when combined with other 
interventions such as lifestyle modification. The study implies that adding metformin to 
the treatment plan of patients with difficulty managing lifestyle modification is an 
imperative implication for clinical practice to attain the best clinical outcome in the 
targeted population.  
Malin et al. (2012) evaluated the combination of exercise with metformin (EM), 
to exercise (E) and metformin (M) independently, placebo (P), and placebo with exercise 
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(PE) in delaying the progression of pre-diabetes to overt T2DM. The result showed an 
overall increase in insulin sensitivity (p < 0.05) relative to the control group and average 
rise of 25-30% higher in insulin sensitivity among the PE group as compared to EM or 
with metformin alone (Malin et al., 2012). The researchers observed that adding 
metformin heightened the full effect of exercise in the metformin and exercise group 
(Malin et al., 2012).  The study affirms the efficiency of metformin in delaying 
progression of T2DM as a monotherapy or as an adjunct to other intervention such as 
increase physical activities.  
Rhee et al (2010) examined the percentage of individuals that could benefit from 
metformin treatment based on the recommendation of the ADA consensus panel in 
delaying type 2 DM or preventing its occurrence. The ADA recommends that individuals 
with both impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), along 
with one additional risk factor such as age 60 years, BMI  greater than 35 , family history 
of diabetes in first-degree relative, elevated triglycerides, reduced HDL cholesterol, or 
A1C 6.0% should be considered for treatment with metformin, lifestyle modification, 
weight loss and physical activity (Rhee et al., 2010). It was found 1 in 12 individuals in 
the target populations met the criteria for consideration of metformin (Rhee et al., 2010). 
The findings of the study outcomes for clinical practice supports the project that early 
identification of individuals at risk of developing T2DM and the need to initiate treatment 
promptly to delay the progression of the disease is significant.  An effective primary 
prevention of T2DM would reduce morbidity, mortality, and financial constraint related 
to its complications (Rhee et al., 2010). The outcome of the investigation supports the use 
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of metformin treatment for diabetes prevention or delay of its progression as an 
imperative clinical implication for practice (Rhee et al., 2010). 
Viskochil, Malin, Blankenship, and Braun (2017) conducted a 12 weeks study to 
determine the effect of metformin alone (M), metformin combined with exercise (ME), 
placebo alone (P), and exercise with placebo (EP) on peripheral insulin sensitivity. A pre-
and post-intervention fasting plasma proinsulin, C-peptide, insulin, and glucose were 
collected. Hepatic insulin extraction, insulin clearance, body weight, and cardio 
respiratory fitness were also measured. The result shows fasting proinsulin was 
unchanged following P and EP. However, a significant increase insulin clearance and a 
decrease fasting proinsulin were seen with M and even greater after EM. Insulin 
clearance was significantly greater following M and EM but was unchanged in P or EP 
(Viskochil et al., 2017). The study indicates that metformin combined with exercise 
training reduced circulating proinsulin, and increased insulin clearance. The outcome not 
only supported the hypothesis that adding metformin to exercise may attenuate the 
training effects of exercise but also a clear indication for clinical use of metformin in the 
management of T2DM to achieve desired outcome (Viskochil et al., 2017). 
Mangahas, Huang, Neher, & Safranek, (2013) performed a systematic analysis of 
three meta-analyses to determine the effectiveness of metformin in preventing diabetes in 
adults at risk of developing diabetes. The analysis demonstrated that metformin 
significantly reduced the risk of the at-risk patient from developing overt diabetes as 
compared to the placebo group. A long-term follow-up of the patients in the Diabetes 
Prevention Program (DPP) also indicates that metformin could delay the progression of 
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T2DM to overt diabetes for as long as 10 years (Mangahas et al., 2011). The study also 
showed that young adults ages 25-44 could benefit more from lifestyle modification 
when combine with metformin than exercise alone. It was also concluded that patients 
ages 65 years and above could benefit more from diet and exercise that could young 
adult. Hence, the ADA strongly recommends utilization of metformin to prevent T2DM 
in patients at risk despite lifestyle modification (Mangahas et al., 2011). The evidence 
strongly supports and reinforces the impact of incorporating metformin for effective and 
efficient management of T2DM based on the algorithm. The outcome of the study also 
showed that combination of metformin and exercise is more beneficial to deter the 
progression of T2DM in adult with high risk of developing T2DM from overt diabetes. 
Metformin as a monotherapy or in conjunction with other therapy to delay the occurrence 
or progression of T2DM is well researched and presented a clear implication for clinical 
practice that could result in effective management of T2DM in primary settings 
(Mangahas et al., 2011; Viskochil et al., 2017; Rhee et al., 2010). 
Evidence Generated for the Doctoral Project 
Participants 
The target population for the project was adults, male and females ages 40 and 
above, who have a BMI of greater than or equal to 25, family history of diabetes, with or 
without existing medical history of hypertension, hyperlipidemia, prediabetes, and 
recently diagnosed in the last 6 to 24 months as T2DM non-insulin dependent. A 
randomized review of the EMR was performed at the project site to identify individuals 
that meet the inclusion criteria. Exclusion criteria include individuals diagnosed with 
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T2DM for more than 24 months and on insulin therapy for diabetes management, 
pregnant, and history of mental health. The ability to intervene at the preventive stage of 
the disease process could prevent overt diabetes in individuals at high risk of developing 
the disease and prevent the individuals recently diagnosed from developing further 
complications related to the disease.  
Procedures 
The execution of the project cannot take place without the approval of the Walden 
IRB.  After the approval of the Walden IRB (Approval #: 03-23-18-0653019) the 
identified potential participants who met the inclusion criteria were contacted for their 
consent and participation in the diabetes education.  The diabetes education was 
conducted on Monday and Tuesday of the month that the organization was screening for 
admission of new patients to the clinic. The clinical director suggested those days to be 
the best period for the diabetes education, because there would less clinical activities on 
those days and the staff would be available to help organize the sessions. The educational 
sessions were held in the organization’s conference room in the morning before lunch 
time.  
On the first day of the educational session, the participants were seated in the 
conference room as they arrive at the clinic. A pen and a paper copy of the consent were 
presented to each participant. It was collected and kept in a folder labeled “consent” and 
kept on the table. After the participants signed the consent, they were given the pre-test 
questionnaire (see Appendix E) and a pen to complete it.   Because the pre-test and the 
post-test (see Appendix E) were the same sets of questionnaires, the word pre-test was 
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circled, and the participants filled out the questionnaire with a pen. I was available in the 
conference room for any questions by the participants as they fill out the questionnaires. 
The result of the pre-test was used to establish their baseline knowledge of diabetes.  The 
questionnaires were kept anonymous and participants’ identification was not required. 
The participants placed their completed pre-test questionnaire in the folder labeled “Pre-
Test Questionnaire”.   
The diabetes education was presented in a power point via the organization’s 
projector in both English (see Appendix F) and Spanish (see Appendix P). I presented the 
English version of the teaching session and Marlin, who is a member of the project team 
and the Spanish interpreter for the organization, presented the Spanish version while I 
stood by for questions. At the end of day one of the program, participants were given a 
copy of the diabetes pamphlet (see Appendix F; Appendix P) with the same content 
delivered based on their language preference. Participants were encouraged to return on 
the second day of the program with any questions or concerns they may have regarding 
the subject discussed or about diabetes in general. 
 On the second day of the educational session, the first few hours were used to 
address any questions or concerns participants had regarding diabetes. The information 
presented the previous day was reinforced to the participants in English by me and in 
Spanish by Marlin. Then the post-test (see Appendix E) with the word posttest circled, 
was distributed to the participants. The participants completed the posttest with a pen. 
Both Marlin and I remained in the room in case there were any questions. The 
questionnaires were kept anonymous and participant identification was not required. The 
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participants placed the completed posttest questionnaire in the folder labeled “Posttest 
Questionnaire”. The consent, the pre-test, and the posttest folders were taken to the 
director’s office where they were locked inside a locked cabinet. 
The results of the pre-test and post-education were compared by the director and 
me. The total number of correct answers before the diabetes education session was 
compared to total number of the correct answers after the educational session to ascertain 
the changes in the participants’ knowledge of the subject matter. The expected successful 
outcome of the diabetes education was a score of 90% or greater on the answered posttest 
questionnaire.  A result below 90% would have called for a repeat of the diabetes 
education which would have been scheduled for the next organization’s screening period. 
However, participants were also encouraged to follow up with their primary care provider 
for screening and management as soon as possible. The patients’ knowledge deficit 
related to diabetes was identified as a major contributing factor to the late diagnosis and 
lack of effective management of T2DM in the target population. The lack of literacy 
related to the disease becomes the driving force to heighten the patients’ knowledge and 
awareness of the disease.   
Instrument 
 The pre- and post-test (see Appendix E) was developed by myself from the NDEI 
based on the diabetes teaching recommendation by the ADA, to evaluate whether the 
diabetes educational session will improve the participants’ knowledge of diabetes, the 
risk factors, and the complications related to the disease. The questionnaire was 
developed to meet the educational need of the target population in accordance with the 
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ADA teaching guidelines to support its validity and reliability. The learning tool 
described diabetes in simple English and Spanish languages at a fifth-grade level for 
maximum understanding by the participants and other readers.  
Protections 
The principle of Health Insurance Portability and Accountability Act (HIPAA) 
was strictly adhered to, to safeguard the participants’ privacy. All the documents were 
maintained in a locked cabinet inside the director’s private office at all times. The data 
transcribed from the raw data collection was stored in a Microsoft word folder named 
“Pre-and Posttest Results” in the organization’s computer system. Access to the 
documents and data were limited to the project team members only. These authorized 
individuals were assigned a password for accountability and security. 
Analysis and Synthesis 
The first objective of the project was to establish use of the diabetes algorithm as 
the standard of care for the management of patients diagnosed with T2DM and patients at 
high risk of developing T2DM at the project site.  To effectively analyze the providers’ 
compliance with the guidelines, the number of patients with diabetes related 
complications such as cardiovascular disease, hyperlipidemia, and peripheral neuropathy 
receiving treatment based on the traditional guidelines was collecetd over a period of 
three months before the implementation of the algorithm. Then the number was 
compared  to the number of patients with diabetes related complications such as 
cardiovascular disease, hyperlipidemia, and peripheral neuropathy treated based on the 
algorithm for a three-month period after implementation of the algorithm. The impact of 
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the guideline in the effective management of T2DM in the target population was 
determined by comparing a 3-month period prior to implementation of the algorithm to 3-
month period after implementation of the algorithm.   
The second objective was to increase the awareness of patients at risk of 
developing T2DM about the disease process and its management. A power point 
presentation was delivered to the identified participants to enhance their knowledge of the 
disease and its complications. A one group pre-and post-test was used to analyze the 
influence of the teaching on patients’ knowledge of the subject discussed. The SPSS 
version 24.0 was used to analyze the paired t-test to evaluate the differences between the 
pre- and post-tests. 
Summary 
The project site has experienced a substantial level of treatment failure of patients 
with T2DM due to lack of standardized clinical guidelines for the treatment of the target 
population. The ongoing treatment failure and its impact cannot be over emphasized. 
Hence, the need for a robust and standardized evidence-based practice to lessen the 
severity of the problem and its impact on clinical outcome is highly imperative. The 
focus of the project was to explore the hypothesis whether early initiation of treatment 
with metformin based on the AACE and the ACE diabetes management algorithms delay 
the progression of T2DM in individuals with high risk of developing the disease and 
prevents complications in individuals diagnosed with the disease.  An extensive literature 
review was completed to validate its reliability and validity, and to ensure the 
effectiveness of the type 2 DM algorithm in the management of patients with T2DM. 
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Databases  PubMed, MEDLINE, CINHAL, National Institutes of Health (NIH), CDC, 
and the Cochrane Library via Walden University were used to conduct the review of 
literature. The analysis and synthesis of the project was performed in two parts. First, to 
compare the number of patients started on metformin based on the algorithm for three 
months prior to the intervention and compared the number with post intervention result. 
Second, a one group pre-and post-test would be utilized to analyze the learning outcome 
of the diabetes teaching among the participants. The enormous impact of early 
identification of individuals at risk of developing type 2 DM and initiation of preventive 
measure with metformin based on the diabetes algorithm is indisputable to the prevention 
















Section 4: Findings and Recommendations 
Introduction 
 The primary purpose of the DNP project was to implement the diabetes 
management algorithm as the standard of care for patients with T2DM at the project site 
based on AACE and ACE guidelines, and increase patients’ knowledge of the disease, its 
process, and complications. A Power Point presentation including the clinical 
recommendations developed based on the AACE and ACE guidelines was sent to all the 
care providers at clinic via the clinic group email address. Patients with diabetes-related 
complications such as cardiovascular disease, hyperlipidemia, and peripheral neuropathy 
who received treatment based on the traditional guidelines for the period between January 
and March was collected and compared to the number of patients with diabetes-related 
complications such as cardiovascular disease, hyperlipidemia, and peripheral neuropathy 
based on the new guidelines for the period between April and June. Also, an extensive 2-
day diabetes education program delivered in both English and Spanish languages was 
provided to patients older than 40 who had a high risk of developing T2DM and were 
newly diagnosed within the last 6 months. To assess the participants’ baseline knowledge 
of the subject, a pre-test was given before the diabetes educational sessions on day one 
and a posttest was provided on day two to determine the change in the participants’ level 
of understanding of T2DM. In this section, the findings, implications, recommendations, 




Findings and Implications 
The practice focused question was: Would early initiation of treatment with 
metformin based on the AACE and the ACE diabetes management algorithms delay the 
progression of T2DM in individuals with high risk of developing the disease and prevents 
complications in individuals diagnosed with the disease? There were two objectives for 
the project. The first objective was to implement the diabetes algorithm as the 
standardized management guidelines to promote initiation of early treatment in 
individuals at risk of developing T2DM and prevent complications in the individuals 
diagnosed. The second project objective was to increase the awareness of patients at risk 
of developing T2DM regarding the disease process and its management.  
A Power Point presentation including the clinical recommendations developed 
based on the AACE and ACE guidelines was sent to all the care providers at the clinic 
via the clinic group email address on March 27, 2018. Two weeks later, 70% (13 of the 
18 volunteer providers) of the clinicians responded. During the providers’ quarterly 
meeting in April, the AACE and ACE guidelines was formally introduced by the director 
to the providers as the clinic’s clinical guidelines to be used by providers for management 
of patients with T2DM or at risk of developing the disease based on the algorithm. The 
clinic’s computer system Athena (see definition of terms) is now equipped with screening 
features that would prompt providers to explore more from patients with a family history 
of T2DM during the initial encounter.  Providers were also provided with the CDC 
prediabetes screening test by the NDPP (see Appendix A) and the patient risk assessment 
tool by the ADA (see Appendix B). All these resources were made available to providers 
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at the project site to promote early identification of individuals at risk, prompt treatment 
initiation to curb treatment failure, and ease the transition from the traditional guidelines 
to the evidence-based diabetes algorithm.  
To analyze the providers’ compliance new guidelines for the management of 
patients with T2DM, the number of patients with diabetes-related complications such as 
cardiovascular disease, hyperlipidemia, and peripheral neuropathy receiving treatment 
based on the traditional guidelines from the months of January through March prior to the 
implementation of the algorithm was compared to the number of patients with diabetes-
related complications such as cardiovascular disease, hyperlipidemia, and peripheral 
neuropathy treated based on the algorithm for the months of April through June after 
implementation of the algorithm. The result of the review from January through March 
yielded 36 patients diagnosed with T2DM who also had hypertension, hyperlipidemia, 
and/-or peripheral neuropathy. Of the 36 participants, 21 (58.3%) were females and 15 
(41.7%) were males.  Ages ranged from 37 through 62, with an average age of 48.3 
years. It was found that the majority had hypertension, neuropathy, hyperlipidemia, and 
just less than half of the group had a combination of hypertension, hyperlipidemia, and 
neuropathy. An average of 61.8% of the participants has one or more diabetes-related 








Descriptive Statistics for Age of the Study Participants Pre- intervention/Implementation 
(n = 36) 
 Frequency Percentage  
Age   
≤ 45 years  12 33.3 
46 to 50 years  13 36.1 
≥ 51 years 11 30.6 
Gender    
Female 21 58.3 
Male 15 41.7 
Hypertension   
Yes 31 86.1 
No 5   13.9 
Neuropathy    
Yes 18 50 
No 18 50 
Hyperlipidemia   
Yes 24 66.7 




The post intervention review of EMR was performed for the months of April 
through June. The result yielded 46 participants. The age of the participants ranged from 
35 to 66 with an average of 45.5.  Among them were 28 (60.9%) females and 18 (39.1%) 
males. The participants were evaluated for diabetes related complications that include 
hypertension, hyperlipidemia, and neuropathy. These diabetes-related complications were 
averaged at 34.06 among the participants (see table 2). 
Table 2 
Descriptive Statistics for Age of the Study Participants Post Intervention/Implementation 
(n = 46) 
 Frequency Percentage  
Age   
≤ 45 years  20 43.5 
46 to 50 years  10 21.7 
≥ 51 years 16 34.8 
Gender    
Female 28 60.9 
Male 18 39.1 
Hypertension   
Yes 11 23.9 
No 35 76.1 
Neuropathy    
Yes 13 28.3 
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No 33 71.7 
Hyperlipidemia   
Yes 23 50.0 
No 23 50.0 
The comparison of the pre-and post-intervention of diabetes related complication 
was performed to evaluate the effective utilization of the diabetes management algorithm 
by the providers. During the pre-intervention EMR review, 31 (86.1%) of the participants 
were diagnosed with hypertension, 18(50.0%) with neuropathy, and 24 (66.7) were 
diagnosed with hyperlipidemia while the post-intervention shows 11(23.9%), 13 (28.3%), 
and 23 (50.0%) respectively (see Figure 3). 
 
Figure 3. Pre and post implemetation of diabetes algorithm. 
A comprehensive diabetes management educational session was held at the 
project’s site. After an extensive randomized review of the EMR, 37 individuals were 
found who met the inclusion criteria. Of these 37 individuals, only 16 responded to the 
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invitation to participate in the diabetes education. It’s not surprising for one to wonder 
why the participation rate was less than 50% of the individuals who met the inclusion 
criteria. One of the reasons is lack of transportation. The clinic is situated in the 
downtown of the city where public transport is not available in the area, and individuals 
are dependent on their own private vehicle, which may be difficult for them to fuel. The 
target population has a very low socioeconomic status such that not all basic needs are 
available to them. Most of the patients depend on families and friends to bring them to 
the clinic for their scheduled appointment.  It is not uncommon for patients to cancel 
appointments in successions due to lack of transportation to the clinic. For the female 
patients, the lack of childcare is another common reason for them to miss their 
appointment. These are some of the reasons why it is difficult for some of these qualified 
participants to make a commitment for the diabetes education. 
 The educational session was conducted for two days. On day one of the session, 
10 female and six male participants were present for the pre-test and the diabetes 
education (see Table 2). However, only 14 participants partook in the posttest on the 
second day of the educational session. The analysis and computation of the paired t-test 
for the pre-test was computed based on the number of participants who completed both 
the pre-test (n = 14) and the posttest only. The average age of the participants based on 
the number of participants that completed the two sessions was 48.5 years (SD = 13.02, n 
= 14; SD = 4.9, n = 14) ranging in age 40 to 57. SPSS version 24.0 was used to analyze 
the paired t-test and to evaluate the differences between the pre and posttests. Analysis of 
the diabetes education program is provided (see Table 3). The mean score on the pre-test 
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was 56.91 while the score on the posttest was 90.72.  The participants’ average pre-test 
and post-test score respectively was 56.91% and 90.72%, an increase of 34.14%, leading 
to 90.72% average score.  
Table 3 
Paired Samples Statistics Diabetes Education Pre and Post test Scores  
 N Mean Standard Deviation  
Pre-Intervention Score 14 56.91 13.02 
Post-Intervention Score 14 90.72 6.46 
 
There was a mean difference of 34.14 between the participants’ pre-test diabetes 
knowledge as compared to their knowledge on the post-test (see Table 4). Conduction of 
the paired difference of the pre-and posttest diabetes education yielded a p < 0.05, 
demonstrating that the outcome of knowledge was not impacted by the number of the 
absentees. The remarkable increase in the posttest average diabetes education score 
indicates a need for diabetes education in the target population. T2DM is very complex 
and the results support that ongoing, adequate, and efficient diabetes education is 










Paired Samples Statistics for Diabetes Education Pre/Post-Intervention Test Scores (n = 
14) 
    95% Confidence 
Interval 
   
Score N Mean  Std. Dev. Lower  Upper t df p 
Pre Intervention  14 56.91 13.02 49.84 63.35    
Post Intervention  14 90.72 6.46 87.35 94.11    
Post compared to Pre  14 34.14 13.99 26.06 42.21 9.13 13 <0.001 
 
Implications 
The target population is faced with a significant knowledge deficit related to their 
T2DM, its disease process, and complications. The wide gap in knowledge indicates a 
need for ongoing assessment of patients’ knowledge of the disease and corresponding 
teaching sessions by clinicians. The goal is identification of individuals at risk of 
developing T2DM with prompt intervention ensuing. However, in most cases these 
individuals are not identified until the overt disease phase is manifested (Forouhi & 
Wareham, 2014). In this case the goal is to delay the progression of the disease and 
thereby prevent complications. T2DM is a multifaceted, chronic, and complex disease 
such that patients’ adequate understanding of the disease is imperative for effective 
management of the disease. The patients’ ability to understand the disease will not only 
support their skills-based learning but it will enhance their sense of empowerment to self-
care management (Baptista et al., 2016). 
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Lack of patients’ awareness of T2DM has been identified as one of the major 
contributing factors to poor patients’ health care outcome in the target population. Thus, 
to achieve efficient transition of care from the clinical setting to the home environment, 
adequate patient education that empowers the patients and emphasizes their role in 
effective self-management is necessary for successful achievement of the individual 
patient’s desired clinical outcome. 
Recommendations 
Early identification of individuals at risk of developing T2DM based on their 
family history, BMI, and age is key to delaying the disease progression and prevention of 
complications. One of my recommendations is for the providers to adopt a culture of 
standardization of care based on the clinical guidelines that support prophylaxis and early 
treatment of the target population. Healthcare insurance organizations such as Medicare 
and Medicaid recommend standardized clinical guidelines as a benchmark for provision 
of care and development patients’ plan of care by providers. According to Krieger (2008) 
standardization of care at all levels is indisputable to eliminate the proximal-distal 
phenomenon. The phenomenon not only creates a class and racial inequality that 
differentially affects the living standards, working conditions, and environmental 
exposures of the dominant and subordinated classes and racial/ethnic groups, but also 
promotes health care disparities (Krieger, 2008). Standardization of care for the target 
population is imperative as the clinic is staffed by volunteer providers which mean that 
the probability of the patients seeing the same provider at each clinic visit is less than 
50%. The use of the diabetes management guidelines as a standard of care for the target 
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population will not only eliminate inconsistency of care among providers, it will also 
promote continuity of care among the target population despite the instability of 
providers’ availability at the project site. 
Early screening of individuals at risk is another key recommendation. Individuals 
with a strong family history of T2DM, age 40 and above, even without elevated BMI 
should be screened for the disease. It was established that an individual could have the 
disease for as long as seven years before the first symptom emerged (Forouhi & 
Wareham, 2014). The new insight gained about T2DM that one can have the disease for 
about 7 years before the onset of the initial symptoms, explains the reason why most 
patients already have complications related to the disease at the time of initial diagnosis. 
From an epidemiological stand point, primary prevention is the goal of effective disease 
management. 
Adequate and efficient patient education must be ongoing. The existence of such 
an educative forum will enable patients to make an informed decision towards their 
health and develop a sense of involvement. Development of a collaborative care approach 
between patients and their providers, along with a customized patient-centered plan of 
care, are imperative to a successful clinical outcome and attainment of a positive health 
care outcome in the target population. 
Contribution of the Doctoral Project Team 
The contribution of the doctoral project team cannot be over emphasized. 
According to Thomas et al. (2008), project planning and team development are integral 
parts and processes of a project and must be developed and initiated simultaneously with 
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the project. After the approval of the project by IRB, I as the project manager met with 
the project team members who consisted of my preceptor who is also the sponsor, the site 
care coordinator and the Spanish interpreter to decide when the diabetes education could 
take place. During the meeting, it was agreed upon to have the teaching done on the 2nd 
and 3rd of April, and every team members’ role was reinforced for clarity.  
The project site care coordinator coordinates the EMR review and serves as the 
liaison between the project team, project manager and the patients. As the project 
manager, I also worked closely with the care coordinator during the EMR review as well 
as reaching out to potential participants via telephone. The Spanish interpreter was the 
one that helped interpret in Spanish. My sponsor, who is the director of the organization 
was responsible for safety of all the correspondence. The consent, the pre-test, and the 
posttest folders were kept in a locked cabinet in his office. The project was a success 
because of the committed team members. 
Strengths and Limitations of the Project 
One of the strengths of the project was that it gave the target population the 
opportunity to reassess their knowledge of T2DM. It allows the participants to have 
clarity about the disease process and the potential complications. The diabetes education 
was an eye opener to the participants as majority of them was not aware of the fact that 
T2DM is a medical condition that affects the diagnosed systemically. The project was 
held over a two-day period which allowed the participants ample time to digest the 
information presented and not be over saturated with information in just few minutes.  
The format allowed for more questions from the participants and provided enough time to 
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allow every participant’s questions to be answered.  Also, the Power Point presentation I 
developed based on the -AACE and ACE-guidelines shared with the providers did not 
only enhance their knowledge of the disease process but also provided them with the 
standard of care evidence-based practice guidelines related to T2DM.  The project 
enabled the providers to embrace prophylaxis measures towards the disease and not just 
focus on treatment modalities only (Crandall et al., 2008; Boyle et al., 2010). 
The only limitation of the project is that the outcome of the project cannot be 
generalized to another hospital, unit, or different patient population. The project site is a 
small community-based clinic with an annual patient population of about 3200 and 
majority are Spanish speaking. The sample size and the combination of the participants 
may not have truly represented the general population for the outcome of the project to be 
generalized. Hence, use of the project outcome at a similar organization is suggested. A 
replication of the project can be conducted in an environment with a more diverse and 
larger population sample to enhance the generalizability of the project (Mishra, 











Section 5: Dissemination Plan 
Introduction 
The purpose of this DNP project was to alleviate treatment failure in patients 
diagnosed with type 2 DM at the project site. Prior to the project, the clinic was using 
traditional guidelines for the management of patients with type 2 DM. Based on the 
traditional guidelines, patients were not screened nor treated prophylactically unless they 
were symptomatic, which is defined as having a non-healing wound, frequent infections, 
sudden weight gain or loss, a HbA1c value greater than 10% in a routine blood test, 
diabetic neuropathy, and elevated urine protein. A retrospective review of patients’ 
medical records over the last 5 years demonstrated that more than 85% of the patients 
with type 2 DM were diagnosed late and analysis of data from the months of January 
through March showed 61.8% of patients had diabetes related complications.  
 During my investigation, I discovered that to alleviate the problem of treatment 
failure in the target population two things must be done. First, was the establishment of 
standards of care based on the AACE and the ACE diabetes management algorithm. 
Secondly, an educational intervention to educate patients about T2DM, its disease 
process, and complications needed to be developed. The results of the pre-and posttest 
diabetes education program showed an increase of 34.14%. The project will be 
disseminated via electronic media to similar community-based clinics, pharmaceutical 
stores, the Florida diabetes prevention center, and Florida public health center in Destin.  
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The manuscript will be developed for consideration for publication in the American 
Journal of Diabetes (AJD). 
Analysis of Self 
Scholar 
According to the AANC (2006) development and evaluation of new practice 
approaches based on nursing theories and theories from other disciplines are some of the 
core elements of a DNP-prepared nurse. As a DNP-prepared nurse scholar, I am equipped 
to assess an organization or a system for potential improvements or changes that could 
enhance the productivity of the organization and the population served. It is also vital for 
me as an agent of change and empowerment to develop and implement health promotion 
and disease prevention activities for individuals, aggregates, and population. Health 
promotion and population health are imperative for positive global wellbeing and health 
outcomes (Kumar & Preetha, 2012). 
Practitioner 
Organizational and systems leadership for quality improvement and systems 
thinking is another key component of a DNP prepared practitioner (AANC, 2006). I 
firmly believe that standardization of practice based on accredited guidelines is 
imperative to achieve universal population positive health outcomes.  
Long-Term Goal 
            My long-term goal as a DNP-prepared nurse is to be actively involved in health 
care politics and policies. My goal is to start with my local constituency and then 
continue to Congress. Health care policy for advocacy in health care is another essential 
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requirement of a DNP-prepared nurse (AACN, 2006). The ability to facilitate health care 
services delivery and engagement in practice to address health care needs is imperative 
(McWilliams, 2009). 
My exposure to the population served at the project site had a significant impact 
on me related to health care policy. The majorities of the patients were of low 
socioeconomic status and had limited access to health care due to lack of health care 
insurance. In Destin, Florida where the clinic is located, most of the available 
employment is either part-time or seasonal. Employees may work as though they are full-
time but without full-time benefits because their employment status is part-time. In this 
case, employers have no obligation to provide those employees with medical insurance 
because they are considered part-time. Non-profit clinics such as my project site are left 
to bridge the gap.  This experience has inspired to encourage other scholars to get 
involved in politics that could influence change in healthcare legislation.  
Lack of health insurance has been identified as the major reason preventing adults 
from seeking health care in a timely manner. They have less access to recommended care, 
receive poorer quality of care, and experience worse health outcomes than insured adults 
(McWilliams, 2009). According to the AACN (2006), political activism and commitment 
to policy development are central elements of professional nursing practice. As a DNP 
graduate I am equipped with the ability to assume a broad leadership role on behalf of the 
population served as well as the nursing profession to influence change in terms of health 
disparities, cultural sensitivity, ethics, the internationalization of health care concerns, 
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access to care, quality of care, health care financing, and issues of equity and social 
justice in the delivery of health care. 
My ability to engage in leadership that integrates and institutionalizes evidence-
based clinical prevention and disease management is indispensable.  As a captain and 
element leader in the United States Air Force (USAF) and a clinical primary care 
provider, my leadership skills have prepared me to be one of the best in the nursing 
profession.  These experiences have also paved the way for my ongoing professional, 
leadership, and scholarly growth.   
Project Manager 
Even though the process of project implementation could be very challenging, it 
is vital to successful implementation of a change into practice. According to the AACN 
(2006), clinical prevention and population health for improving the nation’s health is one 
of the academic requirements for the DNP. Acquired clinical knowledge became the 
driver for me to assess the clinic’s needs related to treatment failure in patients with 
T2DM at the project site. Identification of the clinical problem and the stakeholders were 
critical elements of the project. Involvement of the representatives from the target 
population is not only essential to create a sense of connection and ownership of the 
program among the target population, but also promote support for the implementation, 
acceptance, and sustainability of the programs (Hodges & Videto, 2011). Having a 
strategic plan is a critical part of project development and implementation (ASCO, 2009). 
The process may become cumbersome along the way and one may not be able to 
absolutely control the future of the program at that point but having a strategic plan could 
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help establish a sense of re-direction and the ability to maximize the available options to 
influence the environment and attain the project outcome (ASCO, 2009). 
Completion of the Project 
Challenges and Solutions 
Like any other project, the completion of the DNP project was not without 
challenges. One of the challenges faced during the execution of the project was choosing 
the right topic. As a provider, I knew I wanted to develop a project related to health 
promotion and disease prevention because most of the chronic diseases that I deal with at 
the clinic can be prevented with effective and efficient intervention. I had numerous 
ideas, but the prevention of T2DM in individuals at risk became clear to me due to my 
personal life experience with diabetes. The need to focus on the target population became 
stronger when I got to my clinical site. I have experienced cases of treatment failure in 
my own practice, but it was nothing compared to what I saw at the clinical site. I started 
exploring the literature to enquire more about the clinical problem and about what can be 
done to alleviate it.  
The review of the literature was another challenge that I faced during the project. 
I used the databases PubMed, MEDLINE, CINHAL, NIH, CDC, and the Cochrane 
Library via Walden University. It took me about one week to sort through about 2800 
articles generated by my initial search to obtain the specific literatures that support my 
topic. At the end the result of the literature review gave me more confidence that I was in 
the right direction because of the numerous existing studies that supported the topic.  
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Choosing the right methodology and theoretical framework was another 
challenge. Although, I had an insight of what my project would be, I was unsure of my 
method of data collection, how to evaluate the data, and how to theoretically present the 
information. Materials from my research class such as McEwin and Wills (2014) and 
others were used to overcome the barrier.  Another challenge that I faced during the DNP 
project was finding participants and avenues to perform the diabetes education.  
Contacting the potential participants to participate in the project was harder than I 
anticipated. The organization’s director and the entire staff were very supportive, and 
they helped me throughout the process.   
Insight Gained on the Scholarly Journey 
 Perseverance and dedication are the most important insight that I gained from my 
scholarly journey. During my journey, I work as a full-time parent, active military 
personnel, and as a clinical provider.  Work and family life together can be very 
challenging and become much more challenging when combined with full-time academic 
work. They could be very overwhelming but having a very dedicated mentor is what 
made the difference. Like a marathon runner, sometimes I felt like giving up, but I always 
found the courage to continue until I reached the finish line.   
Summary 
The first purpose of the project was utilization of the diabetes algorithm as the 
standardized guidelines of care for patients at high risk of developing T2DM to increase 
the provider’s initiation of early treatment in the target population. A review of the EMR 
over 3-month period revealed an average of 61.8% in diabetes-related complications 
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among the patients diagnosed with T2DM in the last 24 months. These are conditions that 
could have been prevented if treatment was initiated earlier. It was discovered that most 
providers were not aware that T2DM could be existing in an individual for up to 7 years 
before the presentation of the first sign and symptom. The lack of awareness of the 
disease process by clinicians leads to delay in diagnosis and eventually resulted in 
treatment failure in the target population.  
The second purpose was to increase the awareness of patients at risk of developing 
T2DM about the disease process and its management. The analysis of the diabetes 
education showed a significant means difference of 34.14 from the pre-education and 
paired difference yielded a statistically significant p < 0.05. An ongoing diabetes 
education program is imperative in the target population to eliminate the knowledge 
deficit related to the disease process and its complications. The ability of the target 
population to understand that T2DM is a very complex disease that does not affect only 
one area of the body, but every part of the body, will heighten their self-care management 
treatment regimen. Most patients are gripped with fear of the unknown upon diagnosis 
and are not able to comprehend the potential impacts of the disease onset in their lives. 
Genetic awareness of the disease by individuals with strong family history and early 
intervention to prevent overt diabetes cannot be overemphasized. The goals of the DNP 
project were attained at the end of the project. The patients’ knowledge of T2DM was 
enhanced and the providers’ use of the diabetes management algorithm as standard of 
care has led to increase in early diagnosis and prompt intervention, thereby alleviating 
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Pre Test/Post Test questions 
The purpose of this pre-test/post-test is to evaluate whether this diabetes education 
program improved the participants’ knowledge of diabetes, its risk factors, and 
complications related to the disease.   
1. What do you understand by diabetes?  
a. Too much sugar in the body 
b. Too much sugar in the blood 
c. None of the above 
d. I do not know 
2. How many types of diabetes do exist? 
a. 2. 
b. 1. 
c. I do not know 
3. What conditions put one at risk for diabetes? 
a. Age  
b. Obesity 
c. Family history of diabetes 
d. All the above 
e. None of the above 
4. Identify other medical conditions that can be developed due to diabetes. 
a. Blindness 
b. Heart disease 
c. Loss of extremities 
d. Kidney failure 
e. All the above 
f. None of the above 
5. What can you do when you think you are at risk 
a. Do nothing 
b. Talk to your doctor 
c. Call your pastor 
6. Can diabetes be prevented before it starts in people at high risk? 
Yes □                                           No □ 
7. How can it be prevented? 
a. Eat little or no food 
b. Exercise every day 
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c. Make healthy choice of food and increase physical activities 
d. Follow your doctor’s treatment plan 
e. c & d 
8. How often does your doctor need to check your A1C when you are on medication? 
a. Not at all 
b. Every six months 
c. Every three months. 
9. How do you know when your blood sugar is too high? 
a. Drinking a lot 
b. Urinating a lot 
c. Mouth feels like cotton 
d. Losing weight for no reason 
e. Feeling tired all the time 
f. All the above 
g. None of the above  
10. What will you do when you feel that your blood sugar is high?  
a. Call your doctor 
b. Do nothing 
c. Call your pastor 
11. What will you do when you feel that your blood sugar is too low? 
a. Do nothing 
b. Drink juice like orange juice  
c. call your doctor 
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